{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:26:51Z","timestamp":1792520811163,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on reaching the lungs causes the severe acute respiratory disease, COVID-19. Its first contact with the immune system, likely through the nasal passages and Waldeyer\u2019s ring of tonsils and adenoids, induces mucosal immune responses revealed by the production of secretory IgA (SIgA) antibodies in saliva, nasal fluid, tears, and other secretions within 4 days of infection. Evidence is accumulating that these responses might limit the virus to the upper respiratory tract resulting in asymptomatic infection or only mild disease. The injectable systemic vaccines that have been successfully developed to prevent serious disease and its consequences do not induce antibodies in mucosal secretions of na\u00efve subjects, but they may recall SIgA antibody responses in secretions of previously infected subjects, thereby helping to explain enhanced resistance to repeated (breakthrough) infection. While many intranasally administered COVID vaccines have been found to induce potentially protective immune responses in experimental animals such as mice, few have demonstrated similar success in humans. Intranasal vaccines should have advantage over injectable vaccines in inducing SIgA antibodies in upper respiratory and oral secretions that would not only prevent initial acquisition of the virus, but also suppress community spread<jats:italic>via<\/jats:italic>aerosols and droplets generated from these secretions.<\/jats:p>","DOI":"10.3389\/fimmu.2022.957107","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:14:48Z","timestamp":1660724088000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":111,"title":["Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission"],"prefix":"10.3389","volume":"13","author":[{"given":"Michael W.","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Mestecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674074","article-title":"Pathogenesis and mechanism of gastrointestinal infection with COVID-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00359-2","article-title":"The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection","volume":"14","author":"Gallo","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.056","article-title":"Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms","volume":"160","author":"Livanos","year":"2021","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab686","article-title":"Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes","volume":"74","author":"Jacobs","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9149","article-title":"Airborne transmission of respiratory viruses","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab691","article-title":"Viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory aerosols emitted by patients with coronavirus disease 2019 (COVID-19) while breathing, talking, and singing","volume":"74","author":"Coleman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal immunity in COVID-19: A neglected but critical aspect of SARS-CoV-2 infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.28.21264262","article-title":"No significant difference in viral load between vaccinated and unvaccinated, asymptomatic and symptomatic groups when infected with SARS-CoV-2 delta variant","author":"Acharya","year":"2021","journal-title":"medRxiv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.31.21261387","article-title":"Shedding of infectious SARS-CoV-2 despite vaccination","author":"Riemersma","year":"2021","journal-title":"medRxiv"},{"key":"B10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-415847-4.00001-X","article-title":"The mucosal immune system: Overview","volume-title":"Mucosal immunology, 4th edition. 4 ed","author":"Russell","year":"2015"},{"key":"B11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJM196810242791701","article-title":"Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection","volume":"279","author":"Ogra","year":"1968","journal-title":"New Engl J Med"},{"key":"B12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.102.1.15","article-title":"Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine","volume":"102","author":"Ogra","year":"1969","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915547","article-title":"The common mucosal immune system and current strategies for induction of immune response in external secretions","volume":"7","author":"Mestecky","year":"1987","journal-title":"J Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(95)00016-t","article-title":"Human immune responses to influenza virus vaccines administered by systemic or mucosal routes","volume":"13","author":"Moldoveanu","year":"1995","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.16.21267932","article-title":"A single dose of COVID-19 mRNA vaccine induces airway immunity in COVID-19 convalescent patients","author":"Martinuzzi","year":"2021","journal-title":"medRxiv"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.140.11.3793","article-title":"Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies","volume":"140","author":"Lue","year":"1988","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.759688","article-title":"Detection of antibody responses against SARS-CoV-2 in plasma and saliva from vaccinated and infected individuals","volume":"12","author":"Klingler","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.618685","article-title":"Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals","volume":"11","author":"Butler","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101735","article-title":"Robust and specific secretory IgA against SARS-CoV-2 detected in human milk","volume":"23","author":"Fox","year":"2020","journal-title":"iScience"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03192-20","article-title":"Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19","volume":"12","author":"Pace","year":"2021","journal-title":"mBio"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is oral tolerance a barrier","volume":"179","author":"Mestecky","year":"2007","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-415847-4.00041-0","article-title":"Mechanisms of oral tolerance to soluble protein antigens","volume-title":"Mucosal immunology","author":"Pabst","year":"2015"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.152.9.4663","article-title":"Oral tolerance in humans. T cell but not b cell tolerance after antigen feeding","volume":"152","author":"Husby","year":"1994","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1196\/annals.1309.051","article-title":"Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration","volume":"1029","author":"Moldoveanu","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"B28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/B978-0-12-415847-4.00017-3","article-title":"Mucosal immunoglobulins","volume-title":"Mucosal immunology","author":"Woof","year":"2015"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.152.5.1424","article-title":"Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens","volume":"152","author":"Kutteh","year":"1980","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05730.x","article-title":"Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue","volume":"85","author":"Tarkowski","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/B978-0-12-415847-4.00019-7","article-title":"Immunoglobulin transport and immunoglobulin receptors","volume-title":"Mucosal immunology","author":"Baker","year":"2015"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111450","article-title":"Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. transport data and origin of polymeric immunoglobulin a","volume":"74","author":"Jonard","year":"1984","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.138.2.435","article-title":"Analysis of paraprotein transport into saliva by using anti-idiotype antibodies","volume":"138","author":"Kubagawa","year":"1987","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744887","article-title":"The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines","volume":"12","author":"Chan","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121499","article-title":"Nasal and salivary mucosal humoral immune response elicited by mRNA BNT162b2 COVID-19 vaccine compared to SARS-CoV-2 natural infection","volume":"9","author":"Guerrieri","year":"2021","journal-title":"Vaccines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e15326","DOI":"10.15252\/emmm.202115326","article-title":"BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection","volume":"14","author":"Darwich","year":"2022","journal-title":"EMBO Mol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1128\/mr.52.2.296-303.1988","article-title":"Defense mechanisms involving fc-dependent functions of immunoglobulin a and their subversion by bacterial immunoglobulin a proteases","volume":"52","author":"Kilian","year":"1988","journal-title":"Microbiol Revs"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/s41467-021-25949-x","article-title":"SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms","volume":"12","author":"Fr\u00f6berg","year":"2021","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11040397","article-title":"Mucosal antibody response to SARS-CoV-2 in paediatric and adult patients: a longitudinal study","volume":"11","author":"Chan","year":"2022","journal-title":"Pathogens"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.11.22273690","article-title":"Evaluation of isotype specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults","author":"Thomas","year":"2022","journal-title":"medRxiv"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-415847-4.15001-3","article-title":"Collection and processing of human mucosal secretions","volume-title":"Mucosal immunology","author":"Jackson","year":"2015"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(72)90206-3","article-title":"Immunoglobulins and complement in crevicular fluid, serum and saliva in man","volume":"17","author":"Shillitoe","year":"1972","journal-title":"Archs Oral Biol"},{"key":"B44","article-title":"Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys","volume":"35","author":"Challacombe","year":"1978","journal-title":"Immunology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0765.1971.tb00581.x","article-title":"Quantitative determination of immunoglobuline (IgG, IgA and IgM) and identification of IgA-type in the gingival fluid","volume":"6","author":"Holmberg","year":"1971","journal-title":"J Periodontal Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67728-8","article-title":"Periodontal diseases","volume":"366","author":"Pihlstrom","year":"2005","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(71)90033-1","article-title":"Human secretory immunoglobulins VII. concentrations of parotid IgA and other secretory proteins in relation to the rate of flow and duration of secretory stimulus","volume":"16","author":"Brandtzaeg","year":"1971","journal-title":"Arch Oral Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3109\/00016489609137812","article-title":"Immune functions and immunopathology of the mucosa of the upper respiratory pathways","volume":"116","author":"Brandtzaeg","year":"1996","journal-title":"Acta Otolaryngol"},{"key":"B49","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/B978-0-12-415847-4.00103-8","article-title":"Immunobiology of the tonsils and adenoids","volume-title":"Mucosal immunology","author":"Brandtzaeg","year":"2015"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2008.02.006","article-title":"Tissue distribution of lymphocytes and plasma cells and the role of the gut (letter)","volume":"29","author":"Pabst","year":"2008","journal-title":"Trends Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000028109","article-title":"Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases","volume":"68","author":"Tschernig","year":"2000","journal-title":"Pathobiology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1177\/014107689008300216","article-title":"Immunology of the tonsil: a review","volume":"83","author":"Scadding","year":"1990","journal-title":"J Roy Soc Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1783OC","article-title":"Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways","volume":"183","author":"Brandtzaeg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1997.d01-159.x","article-title":"Nasal lymphoid tissue (NALT) as a mucosal immune inductive site","volume":"46","author":"Wu","year":"1997","journal-title":"Scand J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2101199","article-title":"Cutting edge: SARS-CoV-2 infection induces robust germinal center activity in the human tonsil","volume":"208","author":"Tan","year":"2022","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2002-0230OC","article-title":"Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes","volume":"30","author":"Jahnsen","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.030","article-title":"An essential role for dendritic cells in human and experimental allergic rhinitis","volume":"118","author":"KleinJan","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879575","article-title":"H1N1 influenza virus-infected nasal mucosal epithelial progenitor cells promote dendritic cell recruitment and maturation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250203","article-title":"Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers","volume":"25","author":"Quiding-J\u00e4rbrink","year":"1995","journal-title":"Eur J Immunol"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1172\/JCI119286","article-title":"Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for compartmentalization of effector B cell responses","volume":"99","author":"Quiding-J\u00e4rbrink","year":"1997","journal-title":"J Clin Invest"},{"key":"B63","article-title":"Mucosal vaccines: Overview","volume-title":"Mucosal immunology","author":"Russell","year":"2015"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e2107148118","DOI":"10.1073\/pnas.2107148118","article-title":"Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG","volume":"118","author":"Sun","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Trans Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864775","article-title":"Hexamerization of anti-SARS CoV IgG1 antibodies improves neutralization capacity","volume":"13","author":"Pande","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3201\/eid2801.212220","article-title":"Multistate outbreak of SARS-CoV-2 infections, including vaccine breakthrough infections, associated with large public gatherings, united states","volume":"28","author":"Gharpure","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"B68","first-page":"49","article-title":"Original antigenic sin","volume":"115","author":"Haaheim","year":"2003","journal-title":"A Confounding Issue? Dev Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi8961","article-title":"Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals","volume":"14","author":"Samanovic","year":"2021","journal-title":"Sci Transl Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"Bates","year":"2022","journal-title":"Sci Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00143-8","article-title":"Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden","volume":"22","author":"Nordstr\u00f6m","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00140-2","article-title":"Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study","volume":"22","author":"Cerqueira-Silva","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1282","article-title":"Prior SARS-CoV-2 infection rescues b and T cell responses to variants after first vaccine dose","volume":"372","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj2258","article-title":"Hybrid immunity","volume":"372","author":"Crotty","year":"2021","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.03.018","article-title":"Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity","volume":"185","author":"Rodda","year":"2022","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"KOTETH","DOI":"10.32388\/K0TETH","article-title":"Review of \u201cA single dose of COVID-19 mRNA vaccine induces airway immunity in COVID-19 convalescent patients\u201d","author":"Russell","year":"2022","journal-title":"Qeios"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2449","article-title":"IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans","volume":"84","author":"Czerkinsky","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4292","article-title":"Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel","volume":"375","author":"Prunas","year":"2022","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm3087","article-title":"Indirect protection of children from SARS-CoV-2 infection through parental vaccination","volume":"375","author":"Hayek","year":"2022","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2022.881118","article-title":"A new grand challenge in rhinology: An intranasal COVID vaccine","volume":"3","author":"Scadding","year":"2022","journal-title":"Front Allergy"},{"key":"B85","first-page":"3","article-title":"Historical perspectives on mucosal vaccines","volume-title":"Mucosal vaccines","author":"Russell","year":"2019"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080881","article-title":"Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 and fully protects mice from lethal challenge","volume":"9","author":"King","year":"2021","journal-title":"Vaccines"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2022.01.24.477597","DOI":"10.1101\/2022.01.24.477597","article-title":"Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses","author":"Mao","year":"2022","journal-title":"bioRxiv"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn6868","article-title":"Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model","author":"Langel","year":"2022","journal-title":"Sci Transl Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.16.452733","article-title":"One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2","author":"Tioni","year":"2021","journal-title":"bioRxiv"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100230","article-title":"A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00517-8","article-title":"Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines","volume":"15","author":"Mouro","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1208\/s12249-022-02330-9","article-title":"Factors limiting the translatability of rodent model\u2013based intranasal vaccine research to humans","volume":"23","author":"Cai","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"B95","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-72232-0_6","article-title":"Biological functions of IgA","volume-title":"Mucosal immune defense: Immunoglobulin a","author":"Russell","year":"2007"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879036","article-title":"Humoral response to BNT162b2 vaccine against SARS-CoV-2 variants decays after six months","volume":"13","author":"Lopera","year":"2022","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis342","article-title":"Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step study)","volume":"206","author":"Duerr","year":"2012","journal-title":"J Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.08.008","article-title":"Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences","volume":"27","author":"Matuchansky","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.957107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T01:32:10Z","timestamp":1676424730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.957107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2022.957107"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.957107","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"957107"}}